Seeing Is Believing
Currently out of the existing stock ratings of Andrew Mok, 20 are a SELL (13.33%), 37 are a HOLD (24.67%), 93 are a BUY (62%).
Analyst Andrew Mok, currently employed at BARCLAYS, carries an average stock price target met ratio of 48.76% that have a potential upside of 12.11% achieved within 89 days. Previously, Andrew Mok worked at UBS.
Andrew Mok’s has documented 313 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HUM, Humana at 02-Oct-2025.
Analyst best performing recommendations are on AGL (AGILON HEALTH).
The best stock recommendation documented was for AGL (AGILON HEALTH) at 11/11/2024. The price target of $2 was fulfilled within 1 day with a profit of $0.16 (7.41%) receiving and performance score of 74.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$100
$-0.99 (-0.98%)
$100
5 months 20 days ago
(15-Apr-2025)
2/3 (66.67%)
$8.09 (8.80%)
307
Hold
$101
$0.01 (0.01%)
$103
7 months 2 days ago
(03-Mar-2025)
4/11 (36.36%)
$8.9 (9.66%)
18
Hold
$101
$0.01 (0.01%)
$165
1 years 2 months 5 days ago
(30-Jul-2024)
3/9 (33.33%)
$2.95 (3.01%)
70
Hold
$101
$0.01 (0.01%)
$101
1 years 2 months 11 days ago
(24-Jul-2024)
2/7 (28.57%)
$3.25 (3.32%)
419
Hold
1 years 6 months 10 days ago
(25-Mar-2024)
5/9 (55.56%)
$12.13 (9.49%)
99
Which stock is Andrew Mok is most bullish on?
Which stock is Andrew Mok is most reserved on?
What Year was the first public recommendation made by Andrew Mok?